4.7 Review

Cell-specific epigenetic changes in atherosclerosis

Journal

CLINICAL SCIENCE
Volume 135, Issue 9, Pages 1165-1187

Publisher

PORTLAND PRESS LTD
DOI: 10.1042/CS20201066

Keywords

-

Funding

  1. Heart Foundation of Australia [102492]

Ask authors/readers for more resources

Atherosclerosis is a disease affecting large and medium arteries, leading to life-threatening cerebrovascular and cardiovascular consequences. Single-cell RNA sequencing has identified disease-related cell-specific transcriptomic profiles and new sub-populations of cells. Vascular cells undergo specific transcriptional changes throughout the disease course, with epigenetics playing a crucial role in regulating cellular identity.
Atherosclerosis is a disease of large and medium arteries that can lead to life-threatening cerebrovascular and cardiovascular consequences such as heart failure and stroke and is a major contributor to cardiovascular-related mortality worldwide. Atherosclerosis development is a complex process that involves specific structural, functional and transcriptional changes in different vascular cell populations at different stages of the disease. The application of single-cell RNA sequencing (scRNA-seq) analysis has discovered not only disease-related cell-specific transcriptomic profiles but also novel sub-populations of cells once thought as homogenous cell populations. Vascular cells undergo specific transcriptional changes during the entire course of the disease. Epigenetics is the instruction-set-architecture in living cells that defines and maintains the cellular identity by regulating the cellular transcriptome. Although different cells contain the same genetic material, they have different epigenomic signatures. The epigenome is plastic, dynamic and highly responsive to environmental stimuli. Modifications to the epigenome are driven by an array of epigenetic enzymes generally referred to as writers, erasers and readers that define cellular fate and destiny. The reversibility of these modifications raises hope for finding novel therapeutic targets for modifiable pathological conditions including atherosclerosis where the involvement of epigenetics is increasingly appreciated. This article provides a critical review of the up-to-date research in the field of epigenetics mainly focusing on in vivo settings in the context of the cellular role of individual vascular cell types in the development of atherosclerosis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available